Literature DB >> 8401404

Analysis of skin penetration enhancement based on a two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum: dose-dependent effect of 1-geranylazacycloheptan-2-one on drugs with different lipophilicities.

F Yamashita1, T Yoshioka, Y Koyama, H Okamoto, H Sezaki, M Hashida.   

Abstract

The effects of 1-geranylazacycloheptan-2-one (GACH) on the in vitro skin penetration of seven drugs with various lipophilicities were studied. The penetration of drugs from aqueous vehicle through the guinea pig skin was increased depending on the pretreatment dose of GACH. The largest enhancement was observed for 5-fluorouracil (5-FU) and a bell-shaped relationship was obtained between enhancement ratio and the octanol/water partition coefficients of drugs. Further, Laplace transformed equations for percutaneous absorption of drug were derived from Fick's second law based on a two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum. Through curve-fitting of their equations to penetration profiles using a nonlinear regression program MULTI(FILT) combined with a fast inverse Laplace transform (FILT) algorithm, the action mechanism of GACH was discussed in terms of its effect on the partitioning and diffusivity of drugs in each domain. With an increase in pretreatment dose of GACH, the estimated partition parameters of drugs into the nonpolar route increased but their diffusivities were little affected. The analysis based on a linear free-energy relationship suggested that the increase in partitioning of drugs into the nonpolar route was explained by its increasing polarity with GACH pretreatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401404     DOI: 10.1248/bpb.16.690

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  In vivo evaluation of acyclovir prodrug penetration and metabolism through rat skin using a diffusion/bioconversion model.

Authors:  H Bando; M Sahashi; F Yamashita; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

2.  Theoretical design of prodrug-enhancer combination based on a skin diffusion model: prediction of permeation of acyclovir prodrugs treated with 1-geranylazacycloheptan-2-one.

Authors:  H Bando; T Takagi; F Yamashita; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 3.  Chemical enhancers for transdermal drug transport.

Authors:  K Bauerová; D Matusová; Z Kassai
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

4.  In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum.

Authors:  F Yamashita; H Bando; Y Koyama; S Kitagawa; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

5.  Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax.

Authors:  Sarah A Ibrahim; S Kevin Li
Journal:  J Control Release       Date:  2009-02-06       Impact factor: 9.776

6.  Comparative analysis of percutaneous absorption enhancement by d-limonene and oleic acid based on a skin diffusion model.

Authors:  Y Koyama; H Bando; F Yamashita; Y Takakura; H Sezaki; M Hashida
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.